BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21129249)

  • 21. [Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia].
    Zou XL; Liu T; Meng WT; Huang XO
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1086-90. PubMed ID: 18928601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and activity of glycosylphosphatidylinositol-specific phospholipase d mRNA in bone marrow mononuclear cells isolated from patient with acute myeloid leukemia and their significance].
    Xiao GF; Tang XY; Li X; Zeng C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):15-8. PubMed ID: 20137110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
    Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
    Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
    Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of c-MPL in leukemic stem cells from acute myeloid leukemia patients].
    Yu P; Qiu SW; Rao Q; Lin D; Xing HY; Tang KJ; Tian Z; Wang M; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1052-5. PubMed ID: 23114117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta-catenin and cyclin D1 mRNA levels in newly diagnosed patients with acute myeloid leukemia and their significance].
    Wang YX; Zhang JH; Gu ZW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):304-8. PubMed ID: 19379556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of angiotensin-II type 1 receptor at1 mRNA in myeloid leukemia].
    Peng MY; Wang LL; Liang T; Zhao XL; Wang GP; Chen FP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1418-21. PubMed ID: 21176342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.
    Wampfler J; Federzoni EA; Torbett BE; Fey MF; Tschan MP
    Leuk Res; 2016 Feb; 41():96-102. PubMed ID: 26740055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
    Umeda S; Yamamoto K; Murayama T; Hidaka M; Kurata M; Ohshima T; Suzuki S; Sugawara E; Kawano F; Kitagawa M
    Hematology; 2012 May; 17(3):125-31. PubMed ID: 22664110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of c-fes gene in leukemia cells and its clinical significance].
    Zhang YL; Ren JH; Guo XN; Zhang JN; Wang Y; Qiao SK; Lin FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1429-33. PubMed ID: 20030920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of SALL4 mRNA expression in leukemia by real-time fluorescent quantitative PCR].
    Duan MX; Bi CX; Chen H; Wang N; Li SJ; Xiao XG; Ma XL; Yuan H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1153-6. PubMed ID: 24156424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
    Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease].
    Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Hao L; Wang YZ; Jiang B; Lu XJ; Liu YR; Huang XJ; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):441-5. PubMed ID: 19035174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
    Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
    Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics.
    Tang CY; Lin J; Qian W; Yang J; Ma JC; Deng ZQ; Yang L; An C; Wen XM; Zhang YY; Qian J
    Clin Chem Lab Med; 2014 Dec; 52(12):1843-50. PubMed ID: 24955525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of HoxA10 in acute leukemia and its significance].
    Huang Y; Li WJ; Wei CX; Zhou Z; Nie B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):959-63. PubMed ID: 16403259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression of CD133 in acute leukemia and its clinical significance].
    Zhou Y; Meng HX; Yu Z; Li Q; Wang YF; Mai YJ; Han JL; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):401-4. PubMed ID: 15355691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of ID1 gene in acute myeloid leukemia].
    Lu Y; Wang Q; Mu QT; Chen ZM; Lou JY; Ni WM; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):278-81. PubMed ID: 22781717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].
    Yu MX; Lu Y; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):544-8. PubMed ID: 24078567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.